Compare ADMA Biologics Inc (ADMA) vs Nebius Group NV (NBIS) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
ADMA Biologics Inc vs Nebius Group NV — how do they compare? ADMA Biologics Inc trades at $9.88 (market cap $2.22B), while Nebius Group NV trades at $225.03 (market cap $49.06B). The key difference: Nebius Group NV is far larger — about 22.1× ADMA Biologics Inc's market cap, and Nebius Group NV is trading nearer its 52-week high, ADMA Biologics Inc nearer its low. Which is the better fit depends on your goals.
| ADMA | NBIS | |
|---|---|---|
Market Cap | $2.22B | $49.06B |
Sector | Health | Technology |
52-Week High | $20.38 | $286.69 |
52-Week Low | $7.60 | $64.06 |
Enterprise Value | $2.29B | $49.26B |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About ADMA Biologics Inc
ADMA Biologics is a biopharmaceutical company specializing in plasma-derived therapies for immunodeficient patients. Key products like ASCENIV and BIVIGAM treat primary humoral immunodeficiency and help prevent infectious diseases.
Read more on ADMA →About Nebius Group NV
Nebius Group N.V. is a technology company specializing in AI, machine learning, and cloud computing solutions. The company provides a range of enterprise-level cloud services, including large-scale data processing, advanced analytics, and AI model development and deployment. Nebius Group focuses on serving businesses that require high-performance, scalable, and secure infrastructure to handle complex computational tasks and accelerate their digital transformation.
Read more on NBIS →
